Colgate-Palmolive (CL) income statement
NYSE · Consumer Defensive · Household & Personal Products · 33,600 employees · CEO Noel R. Wallace
- Price
- $95.29 +2.29%
- Market cap
- $76B
- Enterprise value
- $82.2B
- Last report
- Q3 '26 filed 2026-10-30
- Next report
- 2027-01-29 EPS est. $0.97
Colgate-Palmolive (CL) reported revenue of $5.37B for Q3 '26 (+4.6% year on year), operating income of $1.12B (20.9% of revenue) and net income of $751M. Over the last four quarters revenue was $21.3B.
Income statement
| Income statement | Trend | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.95B | $5.07B | $5.06B | $5.03B | $4.94B | $4.91B | $5.11B | $5.13B | $5.23B | $5.32B | $5.36B | $5.37B | |
| Cost of revenue | $2.01B | $2.03B | $1.99B | $1.96B | $1.96B | $1.92B | $2.04B | $2.08B | $2.08B | $2.1B | $2.07B | $2.14B | |
| Gross profit | $2.94B | $3.04B | $3.07B | $3.07B | $2.98B | $2.99B | $3.07B | $3.05B | $3.15B | $3.23B | $3.3B | $3.23B | |
| Research & development | $343M | $0 | $0 | $0 | $355M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Sales & marketing | $0 | $672M | $706M | $694M | $0 | $0 | $678M | $674M | $0 | $0 | $0 | $0 | |
| General & administrative | $0 | $1.27B | $1.25B | $1.31B | $0 | $0 | $1.31B | $1.32B | $0 | $0 | $0 | $0 | |
| Other operating expenses | -$343M | -$78M | -$48M | -$35M | -$355M | $13M | $3M | -$40M | $0 | $6M | $150M | $0 | |
| Operating expenses | $1.8B | $1.86B | $1.91B | $1.96B | $1.89B | $1.91B | $1.99B | $1.95B | $2.07B | $2.08B | $2.28B | $2.11B | |
| Operating income | $1.14B | $1.18B | $1.16B | $1.11B | $1.09B | $1.08B | $1.08B | $1.1B | $1.08B | $1.16B | $1.02B | $1.12B | |
| Interest income | $0 | $0 | $0 | $0 | $16M | $15M | $21M | $21M | $18M | $16M | $17M | $17M | |
| Interest expense | $62M | $58M | $62M | $56M | $66M | $66M | $71M | $67M | $64M | $62M | $62M | $62M | |
| Other non-operating income (gains on investments, FX ...) | $90M | $152M | $86M | $68M | $30M | $57M | $14M | $38M | $906M | $202M | $4M | $41M | |
| Total non-operating income | -$152M | -$210M | -$148M | -$124M | -$96M | -$123M | -$73M | -$105M | -$970M | -$264M | -$66M | -$103M | |
| Income before tax | $988M | $967M | $1.01B | $986M | $994M | $953M | $1.01B | $992M | $107M | $892M | $950M | $1.02B | |
| Income tax | $228M | $238M | $243M | $210M | $214M | $227M | $234M | $226M | $112M | $211M | $231M | $240M | |
| Net income | $718M | $683M | $731M | $737M | $739M | $690M | $743M | $735M | -$37M | $646M | $693M | $751M | |
| EPS (basic) | $0.87 | $0.83 | $0.89 | $0.90 | $0.91 | $0.85 | $0.92 | $0.91 | -$0.05 | $0.81 | $0.87 | $0.94 | |
| EPS (diluted) | $0.87 | $0.83 | $0.89 | $0.90 | $0.90 | $0.85 | $0.91 | $0.91 | -$0.05 | $0.80 | $0.86 | $0.94 | |
| Shares (basic, weighted) | 823M | 823M | 820M | 818M | 818M | 818M | 808M | 808M | 805M | 802M | 797M | 799M | |
| Shares (diluted, weighted) | 825M | 826M | 824M | 823M | 823M | 823M | 816M | 810M | 805M | 805M | 806M | 799M | |
| Depreciation & amortization | $150M | $150M | $157M | $150M | $148M | $148M | $151M | $158M | $173M | $156M | $155M | $159M | |
| EBITDA | $1.2B | $1.18B | $1.23B | $1.19B | $1.21B | $1.17B | $1.22B | $1.22B | $344M | $1.11B | $1.17B | $1.24B |
| Income statement | Trend | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $15.2B | $15.5B | $15.5B | $15.7B | $16.5B | $17.4B | $18B | $19.5B | $20.1B | $20.4B | |
| Cost of revenue | $6.06B | $6.13B | $6.34B | $6.42B | $6.54B | $7.13B | $7.82B | $8.21B | $8B | $8.13B | |
| Gross profit | $9.13B | $9.32B | $9.21B | $9.28B | $9.93B | $10.3B | $10.2B | $11.3B | $12.1B | $12.3B | |
| Research & development | $289M | $285M | $277M | $281M | $290M | $307M | $320M | $343M | $355M | $366M | |
| Sales & marketing | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.72B | $2.7B | |
| General & administrative | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $5.09B | $5.18B | |
| Other operating expenses | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$442M | $692M | |
| Operating expenses | $5.17B | $5.31B | $5.36B | $5.52B | $6.02B | $6.41B | $6.57B | $7.12B | $7.72B | $8.95B | |
| Operating income | $3.96B | $4.01B | $3.85B | $3.76B | $3.91B | $3.89B | $3.59B | $4.13B | $4.38B | $3.31B | |
| Interest income | $50M | $51M | $50M | $47M | $19M | $17M | $14M | $55M | $67M | $75M | |
| Interest expense | $149M | $153M | $193M | $192M | $160M | $117M | $167M | $287M | $292M | $267M | |
| Other non-operating income (gains on investments, FX ...) | $73M | $369M | $193M | $269M | $104M | $682M | $758M | $452M | $135M | -$932M | |
| Total non-operating income | -$222M | -$522M | -$386M | -$461M | -$264M | -$799M | -$925M | -$739M | -$427M | -$247M | |
| Income before tax | $3.74B | $3.49B | $3.46B | $3.3B | $3.65B | $3.09B | $2.66B | $3.39B | $3.96B | $3.06B | |
| Income tax | $1.15B | $1.31B | $906M | $774M | $787M | $749M | $693M | $937M | $907M | $798M | |
| Net income | $2.44B | $2.02B | $2.4B | $2.37B | $2.7B | $2.17B | $1.79B | $2.3B | $2.89B | $2.13B | |
| EPS (basic) | $2.74 | $2.30 | $2.76 | $2.76 | $3.15 | $2.56 | $2.13 | $2.78 | $3.53 | $2.64 | |
| EPS (diluted) | $2.72 | $2.28 | $2.75 | $2.75 | $3.14 | $2.55 | $2.13 | $2.77 | $3.51 | $2.63 | |
| Shares (basic, weighted) | 892M | 882M | 871M | 859M | 857M | 845M | 836M | 827M | 818M | 809M | |
| Shares (diluted, weighted) | 898M | 888M | 873M | 861M | 859M | 848M | 839M | 829M | 823M | 811M | |
| Depreciation & amortization | $443M | $475M | $511M | $519M | $539M | $556M | $545M | $567M | $605M | $630M | |
| EBITDA | $4.33B | $4.12B | $4.17B | $4.01B | $4.35B | $3.76B | $3.37B | $4.25B | $4.85B | $4.87B |
Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.
Revenue, operating income and growth
quarterlyMargins
quarterlyCosts as % of revenue
quarterlyThe other statements
Sources
Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30
Data as of 2026-11-01